Gilead Sciences, Inc. (GILD) Misses Q4 EPS by 8c, Sales Top Slightly
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Wall Street ends lower, off record highs, as Treasury yields climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Price: $146.85 +1.82%
EPS Growth %: -14.2%
Financial Fact:
Shares used in per share calculation - basic: 1.32B
Today's EPS Names:
AEHR, VFS, CMTL, More
EPS Growth %: -14.2%
Financial Fact:
Shares used in per share calculation - basic: 1.32B
Today's EPS Names:
AEHR, VFS, CMTL, More
Join SI Premium – FREE
Gilead Sciences, Inc. (NASDAQ: GILD) reported Q4 EPS of $0.97, $0.08 worse than the analyst estimate of $1.05. Revenue for the quarter came in at $2.2 billion versus the consensus estimate of $2.18 billion.
For earnings history and earnings-related data on Gilead Sciences, Inc. (GILD) click here.
For earnings history and earnings-related data on Gilead Sciences, Inc. (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Some Said Inflation Risks Had Become More Skewed To Upside - FOMC Minutes
- Constellation Brands (STZ) PT Lowered to $155 at Goldman Sachs
- Levi Strauss beats profit forecasts, shares edge higher
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
